The importance of matrix metalloproteinases in the development of atrial fibrillation in obesity
- 作者: Podzolkov V.1, Tarzimanova A.1, Bragina A.1, Gataulin R.1, Oganesyan K.1, Pokrovskaya A.1, Osadchy K.1
-
隶属关系:
- Sechenov First Moscow State Medical University (Sechenov University)
- 期: 卷 93, 编号 12 (2021)
- 页面: 1451-1456
- 栏目: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/72182
- DOI: https://doi.org/10.26442/00403660.2021.12.201178
- ID: 72182
如何引用文章
全文:
详细
Background. One of the trends in modern cardiology is the study of the matrix metalloproteinase (MMP) system. Currently, an increase in plasma concentrations of some MMPs and their tissue inhibitors is considered as one of the earliest biochemical markers of myocardial fibrosis in various diseases of the cardiovascular system. Discusses the importance of MMP in the development of atrial fibrillation (AF).
Aim. To study the effect of the MMP system on the development of AF in obese patients.
Materials and methods. The study included 105 patients with a body mass index of more than 30 kg/m2. Depending on the presence of AF, the patients were divided into 2 groups. The criterion for inclusion of patients in group 1 was the presence of documented AF paroxysm in 55 obese patients. The comparison group (group 2) consisted of 50 obese patients without heart rhythm disorders. When patients were included in the study, in order to assess the severity of visceral obesity, all patients underwent a general clinical examination, echocardiography. To determine the activity of the MMP system, venous blood was taken from patients.
Results. Significantly higher values of MMP-9 were detected in patients with obesity and paroxysmal AF – 315.7±53.4 ng/ml than in patients with obesity without heart rhythm disorders – 220.9±54.7 ng/ml (p=0.002); the values of tissue inhibitor of metalloproteinase 1 were 185.3±42.2 and 119.2±42.6 ng/ml, respectively (p=0.007). In patients with obesity and paroxysmal AF, a correlation of moderate strength between the level of MMP-9 and the volume of left atrium and a direct dependence of moderate strength between the ratio of waist volume to height and the plasma values of MMP-9 was revealed. The MMP-9 index (AUC 0.92) had a high diagnostic value for determining the probability of having a paroxysmal form of AF in obese patients. With an increase in the level of MMP-9 more than 295 ng/ml, it is possible to predict the presence of paroxysmal AF in obese patients with a sensitivity of 74.5% and a specificity of 94%.
Conclusion. In patients with obesity and paroxysmal AF, a significant increase in the parameters of the MMP system (MMP-9 and tissue inhibitor of metalloproteinase 1) was revealed when compared with obese patients without heart rhythm disorders (p<0.05). With an increase in MMP-9 of more than 285 ng/ml in obese patients, the appearance of AF with a sensitivity of 74.5% and a specificity of 94% can be predicted.
作者简介
Valerii Podzolkov
Sechenov First Moscow State Medical University (Sechenov University)
Email: podzolkov@list.ru
ORCID iD: 0000-0002-0758-5609
д-р мед. наук, проф., зав. каф. факультетской терапии №2, дир. клиники факультетской терапии №2
俄罗斯联邦, MoscowAida Tarzimanova
Sechenov First Moscow State Medical University (Sechenov University)
编辑信件的主要联系方式.
Email: tarzimanova@mail.ru
ORCID iD: 0000-0001-9536-8307
д-р мед. наук, проф. каф. факультетской терапии №2
俄罗斯联邦, MoscowAnna Bragina
Sechenov First Moscow State Medical University (Sechenov University)
Email: anna.bragina@mail.ru
ORCID iD: 0000-0002-2699-1610
д-р мед. наук, проф. каф. факультетской терапии №2
俄罗斯联邦, MoscowRadik Gataulin
Sechenov First Moscow State Medical University (Sechenov University)
Email: placespecial@yandex.ru
ORCID iD: 0000-0002-8782-0380
аспирант каф. факультетской терапии №2
俄罗斯联邦, MoscowKarine Oganesyan
Sechenov First Moscow State Medical University (Sechenov University)
Email: tarzimanova@mail.ru
ORCID iD: 0000-0003-3580-7229
зав. терапевтическим отд-нием университетской клинической больницы №4
俄罗斯联邦, MoscowAnna Pokrovskaya
Sechenov First Moscow State Medical University (Sechenov University)
Email: a.e.pokrovskaya@mail.ru
ORCID iD: 0000-0002-8875-9032
канд. мед. наук, доц. каф. факультетской терапии №2
俄罗斯联邦, MoscowKonstantin Osadchy
Sechenov First Moscow State Medical University (Sechenov University)
Email: anna.bragina@mail.ru
ORCID iD: 0000-0001-8202-4492
канд. мед. наук, доц. каф. факультетской терапии №2
俄罗斯联邦, Moscow参考
- ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. doi: 10.1093/eurheartj/ehaa612
- Abed HS, Samuel CS, Lau DH, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10(1):90e100. doi: 10.1016/j.hrthm.2012.08.043
- Goudis CA, Korantzopoulos P, Ntalas IV, et al. Obesity and atrial fibrillation: A comprehensive review of the pathophysiological mechanisms and links. J Cardiol. 2015;66(5):361-9. doi: 10.1016/j.jjcc.2015.04.002
- Murphy G, Nagase H. Localizing matrix metalloproteinase activities in the pericellular environment. FEBS J. 2011;278(1):2-15. doi: 10.1111/j.1742-4658.2010.07918.x
- Thorp EB. Contrasting inflammation resolution during atherosclerosis and post myocardial infarction at the level of monocyte/macrophage phagocytic clearance. Front Immunol. 2012;3:39. doi: 10.3389/fimmu.2012.00039
- Hsu TW, Kuo KL, Hung SC, et al. Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9. PLoS One. 2013;8(7):e70132. doi: 10.1371/journal.pone.0070132
- Nascimento Dda C, Durigan Rde C, Tibana RA, et al. The response of matrix metalloproteinase-9 and -2 to exercise. Sports Med. 2015;45(2):269-78. doi: 10.1007/s40279-014-0265-8
- Heo SH, Cho CH, Kim HO, et al. Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J Clin Neurol. 2011;7(2):69-76. doi: 10.3988/jcn.2011.7.2.69
- Lewkowicz J, Knapp M, Tankiewicz-Kwedlo A. MMP-9 in atrial remodeling in patients with atrial fibrillation. Ann Cardiol Angeiol (Paris). 2015;64(4):285-91. doi: 10.1016/j.ancard.2014.12.004
- Abe I, Teshima Y, Kondo H. Association of fibrotic remodeling and cytokines/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation. Heart Rhythm. 2018;15(11):1717-27. doi: 10.1016/j.hrthm.2018.06.025
- Wu G, Wang S, Cheng M, et al. The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation. Clinics (Sao Paulo). 2016;71(5):251-6. doi: 10.6061/clinics/2016(05)02
- Hopps E, Caimi G. Matrix metalloproteases as a pharmacological target in cardiovascular diseases. Eur Rev Med Pharmacol Sci. 2015;19(14):2583-9.
- Fox CS, Gona P, Hoffmann U, et al. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation. 2009;119(12):1586-91. doi: 10.1161/CIRCULATIONAHA.108.828970
- Gaborit B, Venteclef N, Ancel P, et al. Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical periatrial, periventricular, or pericoronary location. Cardiovas Res. 2015;108:62-73. doi: 10.1093/cvr/cvv208
- Venteclef N, Guglielmi V, Balse E, et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipofibrokines. Eur Heart J. 2015;36(13):795-805a. doi: 10.1093/eurheartj/eht099